Allogene Therapeutics, Inc. (ALLO) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Allogene Therapeutics, Inc., Fate Therapeutics, Inc..Total Return (%)
Allogene Therapeutics, Inc. (ALLO)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Allogene Therapeutics, Inc.
ALLO
Fate Therapeutics, Inc.
FATE
| Metric | Allogene Therapeutics, Inc. (ALLO) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $2.04 | $1.16 |
| Change | 0.05 (2.77%) | -0.07 (-5.69%) |
| Market Cap | $0.43B | $0.14B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.47 | -0.69 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $5.78 | $8.83 |
| 52-Week Low | $1.32 | $1.04 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.59 | $-1.55 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ALLO | 5.70% | 5.70% | -60.16% | -92.44% | -91.84% | -91.84% |
| FATE | -10.77% | -10.77% | -83.75% | -96.03% | -76.66% | -76.71% |